Comparative Study and Enlightenment on Innovation Achievements of Pharmaceutical Industry in Liaoning Province  

作　　者：Tao Na Tian Lijuan 

机构地区：[1]School of Business Administration,Shenyang Pharmaceutical University,Shenyang 110016,China

出　　处：《Asian Journal of Social Pharmacy》2022年第3期214-221,共8页亚洲社会药学（英文）

摘　　要：Objective To promote the innovation and development of pharmaceutical industry in Liaoning Province.Methods Literature study and comparative study were used to investigate the current situation and problems of innovation-driven development of pharmaceutical industry in Liaoning Province by comparing data of Heilongjiang,Jilin,Shandong,and Jiangsu from four aspects of priority review and approval,consistency evaluation of generic drugs,new drugs on the market,and scientific and technological innovation achievements.Results and Conclusion In terms of innovation-driven development,pharmaceutical industry in Liaoning Province has the following problems,such as small scale,weak transformation of scientific and technological achievements,tough business environment,and single platform module of scientific and technological achievements.Combined with the actual development of pharmaceutical industry in Liaoning province,the government should give full play to its leading role and guide“Benxi Pharmaceutical Capital”to establish characteristic industrial cluster and incubation park.After high quality enterprises and high-level innovative talents get together,enterprises can analyze their actual situation to plan R&D layout,focusing on the input-output ratio.Meanwhile,the benign development of the enterprises,universities and research institutes should be promoted to integrate technical innovation and product supply.This can enhance the cooperation among the government,enterprise,university,and research institute,and provide reference for further development of pharmaceutical industry in Liaoning province.

关 键 词：Liaoning pharmaceutical industry innovation-driven innovative product 

分 类 号：R96[医药卫生—药理学]